Difference between revisions of "Template:Cardiac stimulants excluding cardiac glycosides"
Jump to navigation
Jump to search
imported>Zyxw (convert to Navbox generic, replace commas with bullets) |
imported>BrandonXLF |
||
| (41 intermediate revisions by 17 users not shown) | |||
| Line 1: | Line 1: | ||
| − | {{Navbox | + | {{Navbox |
| − | | name = | + | | name = Cardiac stimulants excluding cardiac glycosides |
| − | | title = [[ | + | | title = [[Cardiac stimulant]]s excluding cardiac glycosides ([[ATC code C01#C01C|C01C]]) |
| − | | list1 = [[Dobutamine]] | + | | state = {{{state|autocollapse}}} |
| + | | listclass = hlist | ||
| + | |||
| + | | group1 = [[epinephrine|Adrenergic]] and<BR>[[dopaminergic]] agents | ||
| + | | list1 = {{Navbox|subgroup | ||
| + | |||
| + | | group1 = [[Adrenergic agonist]]s | ||
| + | | list1 = {{Navbox|subgroup | ||
| + | |||
| + | | group1 = α | ||
| + | | list1 = | ||
| + | * [[Metaraminol]] | ||
| + | * [[Phenylephrine]] | ||
| + | * [[Methoxamine]] | ||
| + | * [[Norfenefrine]] | ||
| + | * [[Synephrine|Oxedrine]] | ||
| + | * [[Midodrine]] | ||
| + | * [[Mephentermine]] | ||
| + | |||
| + | | group2 = β | ||
| + | | list2 = | ||
| + | * [[Dobutamine]] | ||
| + | * [[Arbutamine]] | ||
| + | * [[Isoprenaline]] | ||
| + | * [[Prenalterol]] | ||
| + | |||
| + | | group3 = mixed | ||
| + | | list3 = | ||
| + | * [[Amezinium metilsulfate]] | ||
| + | * [[Droxidopa]] | ||
| + | * [[Epinephrine]] # | ||
| + | * [[Norepinephrine (medication)|Norepinephrine]] | ||
| + | * [[Etilefrine]] | ||
| + | |||
| + | }} | ||
| + | |||
| + | | group2 = [[Dopamine agonist]]s | ||
| + | | list2 = | ||
| + | * [[Fenoldopam]] | ||
| + | |||
| + | | group3 = Both | ||
| + | | list3 = | ||
| + | * [[Dopamine]] # | ||
| + | * [[Dopexamine]] | ||
| + | * [[Ibopamine]] | ||
| + | * [[Octopamine]] | ||
| + | |||
| + | | group4 = Unknown/ungrouped | ||
| + | | list4 = | ||
| + | * [[Dimetofrine]] | ||
| + | * [[Gepefrine]] | ||
| + | * [[Cafedrine]] | ||
| + | * [[Theodrenaline]] | ||
| + | |||
| + | }} | ||
| + | |||
| + | | group2 = [[Phosphodiesterase inhibitor]]s ([[PDE3 inhibitor|PDE3I]]) | ||
| + | | list2 = | ||
| + | * [[Amrinone]] | ||
| + | * [[Milrinone]] | ||
| + | * [[Enoximone]] | ||
| + | * [[Bucladesine]] | ||
| + | |||
| + | | group3 = Other cardiac stimulants | ||
| + | | list3 = | ||
| + | * [[Angiotensinamide]] | ||
| + | * [[Xamoterol]] | ||
| + | * [[Levosimendan]] | ||
| + | * [[Pimobendan]] | ||
| + | |||
| + | | belowstyle = background: transparent; padding: 0px; | ||
| + | | below = {{PharmNavFootnote}} | ||
| + | |||
}}<noinclude> | }}<noinclude> | ||
| − | [[Category: | + | {{collapsible option}} |
| + | [[Category:Cardiac stimulants]] | ||
| + | [[Category:Drug_templates by ATC]] | ||
</noinclude> | </noinclude> | ||
Latest revision as of 21:05, 4 January 2020
Initial visibility: currently defaults to autocollapse
To set this template's initial visibility, the |state= parameter may be used:
|state=collapsed:{{Cardiac stimulants excluding cardiac glycosides|state=collapsed}}to show the template collapsed, i.e., hidden apart from its title bar|state=expanded:{{Cardiac stimulants excluding cardiac glycosides|state=expanded}}to show the template expanded, i.e., fully visible|state=autocollapse:{{Cardiac stimulants excluding cardiac glycosides|state=autocollapse}}
If the |state= parameter in the template on this page is not set, the template's initial visibility is taken from the |default= parameter in the Collapsible option template. For the template on this page, that currently evaluates to autocollapse.